That medical venture capitalist who had the requisite clearances, who was willing to risk the most capital and make the most daring credible promises, is now taking primary point on developing the actual treatment plan.
This plan is going to need, like, around 100 custom proteins, only 80 of which actually exist in the literature.
Is this matter urgent enough that Exception Handling could possibly... you know... happen to find those other 20 necessary protein designs in a forgotten filing cabinet somewhere?